{
  "ticker": "LLY",
  "target_date": "2025-04-28",
  "actual_date": "2025-04-28",
  "collected_at": "2025-12-08T11:41:41.873135",
  "price": {
    "open": 865.48,
    "high": 877.23,
    "low": 859.49,
    "close": 872.2955932617188,
    "volume": 3457600,
    "change_1d_pct": -0.82,
    "change_7d_pct": 19.38,
    "change_30d_pct": 7.84
  },
  "technicals": {
    "rsi_14": 73.84,
    "sma_20": 786.33,
    "sma_50": 828.3,
    "macd": 10.902,
    "macd_signal": -5.719,
    "macd_histogram": 16.62,
    "bb_upper": 894.19,
    "bb_lower": 678.46,
    "price_vs_sma20_pct": 10.93,
    "price_vs_sma50_pct": 5.31,
    "volume_ratio": 0.85
  },
  "fundamentals": {
    "market_cap": 890742964224,
    "pe_ratio": 48.683304,
    "forward_pe": 43.84935,
    "price_to_book": 37.410625,
    "price_to_sales": 14.990676,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.64,
    "pct_from_52w_low": 59.29
  },
  "macro": {
    "spy": {
      "price": 547.71,
      "change_1d_pct": 0.04,
      "change_7d_pct": 4.64
    },
    "vix": {
      "level": 25.15,
      "signal": "HIGH_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.22
    },
    "dollar_index": {
      "level": 99.01
    },
    "gold": {
      "price": 3332.5
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "Stocks Churn as Busy Earnings Week to Test Rally: Markets Wrap",
      "source": "Yahoo",
      "datetime": 1745852029,
      "summary": "(Bloomberg) -- Wall Street traders bracing for a deluge of corporate earnings and key economic data sent stocks churning on Monday as they awaited more insights on the impacts of President Donald Trump\u2019s trade war.Most Read from BloombergNewsom Says California Is Now the World\u2019s Fourth-Biggest Econo",
      "url": "https://finnhub.io/api/news?id=068217683677097bf96c79dd9b3261221bf57f20be61457d35169a1cde3284dd"
    },
    {
      "headline": "Zymeworks: A Strong Buy With Newly-Approved Cancer Drug, Excellent Financials, And Expansive Pipeline",
      "source": "SeekingAlpha",
      "datetime": 1745861583,
      "summary": "Zymeworks receives Strong Buy rating, driven by FDA-approved Ziihera, advancing R&D, strong partnerships, and financial health.",
      "url": "https://finnhub.io/api/news?id=a4bccbebae64b2288cd7ad17e1db731193cbf06cd0ff56fd86ad9036211ba03b"
    },
    {
      "headline": "Eli Lilly: Why Orforglipron Matters, A Lot",
      "source": "SeekingAlpha",
      "datetime": 1745856808,
      "summary": "Eli Lilly and Company's orforglipron had good results in Type 2 diabetes trials, potentially becoming the first scalable oral obesity drug. Click for my LLY update.",
      "url": "https://finnhub.io/api/news?id=7318416a401515a3ba029aeb5873035beacd58e657832ccd46193eeed2e5e3bc"
    },
    {
      "headline": "Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?",
      "source": "Yahoo",
      "datetime": 1745856480,
      "summary": "Let's look at five pharma and drug companies, PFE, LLY, AMGN, BIIB and REGN, which are scheduled to release their first-quarter 2025 results later this week.",
      "url": "https://finnhub.io/api/news?id=0baf42e6b97681e5c18609832f6de6672ad5abe20f1451bccc8d6c2b17fbbd65"
    },
    {
      "headline": "Is Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)",
      "source": "Yahoo",
      "datetime": 1745854860,
      "summary": "Investor focus is likely to be on the sales numbers of LLY's tirzepatide medicines Mounjaro and Zepbound.",
      "url": "https://finnhub.io/api/news?id=f05c5d8f47879ea9825021b33b69461d09181704e4eb7182b07ce3d02319575c"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/xslF345X05/wk-form4_1745353361.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353273.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000122/xslF345X05/wk-form4_1745353273.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353160.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000120/xslF345X05/wk-form4_1745353160.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745352964.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000118/xslF345X05/wk-form4_1745352964.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745352850.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000116/xslF345X05/wk-form4_1745352850.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}